Funding for this research was provided by:
Japan Agency for Medical Research and Development (17bk0104035h0003, 15bk0104049h0001)
Received: 21 August 2018
Accepted: 28 November 2018
First Online: 13 December 2018
Ethics approval and consent to participate
: This clinical study has been approved by the Ethical Committee and Internal Review Board of Osaka University. Therefore, after the patient in the present case gave his informed consent, we conducted this procedure according to the Guidelines on Clinical Research Using Human Stem Cells from the Japanese Ministry of Health, Labour, and Welfare (UMIN ID; UMIN000003273; ExternalRef removed
: We have already gotten consent for publication from patient.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.